Help Advance Polymyalgia Rheumatica (PMR) Research from Home and Earn $100 The Vasculitis Foundation is reaching out to the Polymyalgia Rheumatica (PMR) patient community to raise awareness about an opportunity for patients to help advance research from home. You need to be 18 years of age or older with PMR…...
Chronic Illness: Wegener’s Vasculitis Series with Art Diaz
Formerly called Wegener’s granulomatosis, granulomatosis with polyangiitis (GPA) is a form of vasculitis—a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage vital organs and tissues. It is a rare disease that, like so many others, effects each person differently. In…...
ChemoCentryx Announces Filing of Amendment to NDA Submission and Extension of the PDUFA Review Period for Avacopan in the Treatment of ANCA-Associated Vasculitis
07/06/21 ChemoCentryx Announces Filing of Amendment to NDA Submission and Extension of the PDUFA Review Period for Avacopan in the Treatment of ANCA-Associated Vasculitis SAN CARLOS, Calif., July 06, 2021 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that, following consultations with the U.S. Food and Drug Administration (FDA),…...
The American College of Rheumatology/Vasculitis Foundation Release Three New Guidelines for Treatment of Vasculitis
FOR IMMEDIATE RELEASE July 9, 2021 Media Contact Amanda Head (Corna) [email protected] 404-679-5330 The American College of Rheumatology/Vasculitis Foundation Release Three New Guidelines for Treatment of Vasculitis ATLANTA — The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released three new guidelines for the treatment and management of systemic vasculitis. Vasculitis is a group of…...
VF Awards Research Grant to Pulmonary/Critical Care Medicine Physician at OSU
Lynn A. Fussner, MD, Assistant Professor at The Ohio State University (OSU), Division of Pulmonary, Critical Care, and Sleep Medicine, has been awarded a one-year grant from the Vasculitis Foundation (VF) for her study, “Role of Monocytes and Alpha-1 Antitrypsin in ANCA-Associated Vasculitis.” Dr. Fussner’s goal is to identify better…...
